Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapy
Psycho-Oncology · 2023
DOI: 10.1002/pon.6229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psycho-Oncology, 2023. Verfasst von Eva E van Grinsven und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology & Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Brain Neoplasms, Cognition Disorders, Cognitive Dysfunction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.
Abstract (Originalsprache)
Objective
Patients with brain metastases (BrMs) are a heterogeneous population, with almost 50% experiencing cognitive impairment before brain radiotherapy. Defining pre‐radiotherapy cognitive profiles will aid in understanding of the cognitive vulnerabilities and offer valuable insight and guidance for tailoring interventions.
Methods
The study population consisted of 58 adult patients with BrMs referred for radiotherapy. A semi‐structured interview and comprehensive battery including 10 neuropsychological tests were used to assess subjective and objective cognitive performance prior to radiotherapy.
Results
A majority (69%) of patients report decline in cognitive performance compared to their premorbid level (i.e. pre‐cancer). Objective testing revealed memory (52%), processing speed (33%) and emotion recognition (29%) deficits were most frequent. 21% of patients had no cognitive deficits while 55% had deficits (−1.5SD) in at least two cognitive domains. Hierarchical cluster analysis based on patient deficit profiles identified four clusters: (I) no or limited cognitive deficits selectively restricted to processing speed or executive function, (II) psychomotor speed deficits, (III) memory deficits and (IV) extensive cognitive deficits including memory. No patient or clinical‐related (e.g. age, number of BrMs, previous treatment) differences were found between clusters.
Conclusions
Patterns of cognitive performance in patients with BrMs are heterogeneous, with most experiencing at least some degree of neurocognitive dysfunction. We identified four meaningful cognitive clusters. Stability of these clusters over time and in different samples should be assessed to advance understanding of the cognitive vulnerability of this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology & Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
- Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Experimental Psychology and Helmholtz Institute, Utrecht University, Utrecht, The Netherlands.
ORCID-Profile: Eva E van Grinsven
Förderung
- KWF Kankerbestrijding
Zitieren
APA
van Grinsven, E. E., Cialdella, F., Verhoeff, J. J. C., Philippens, M. E. P., & van Zandvoort, M. J. E. (2023). Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapy. Psycho-Oncology. https://doi.org/10.1002/pon.6229
Vancouver
van Grinsven EE, Cialdella F, Verhoeff JJC, Philippens MEP, van Zandvoort MJE. Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapy. Psycho-Oncology. 2023. doi:10.1002/pon.6229
BibTeX
@article{vanGrinsven2023,
author = {van Grinsven, Eva E and Cialdella, Fia and Verhoeff, Joost J C and Philippens, Marielle E P and van Zandvoort, Martine J E},
title = {Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapy},
journal = {Psycho-Oncology},
year = {2023},
doi = {10.1002/pon.6229}
}
EUVIMED